SUNA 2008 - Efficacy and Safety of Silodosin for the Treatment of Signs and Symptoms of BPH: Pooled Results of Two Randomized, Placebo-Controlled Studies and Results of a 9-Month Open-Label Extension Study - Highlight
PHILADELPHIA, PA, USA (UroToday.com) - Silodosin is an alpha blocker which was recently approved by the FDA for men with BPH.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
